Listed

Corcept Therapeutics Inc

CORTNasdaqCIK 1088856HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$256.1m, Q2 FY2026
Operating income$41.3m, Q2 FY2026
Net income$43.0m, Q2 FY2026
Corcept Therapeutics Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m124Revenue, Q3 FY2023, three months to 2023-09-30$123.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure135Revenue, Q4 FY2023, three months to 2023-12-31$135.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure147Revenue, Q1 FY2024, three months to 2024-03-31$146.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure164Revenue, Q2 FY2024, three months to 2024-06-30$163.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure183Revenue, Q3 FY2024, three months to 2024-09-30$182.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure182Revenue, Q4 FY2024, three months to 2024-12-31$181.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure157Revenue, Q1 FY2025, three months to 2025-03-31$157.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure194Revenue, Q2 FY2025, three months to 2025-06-30$194.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure208Revenue, Q3 FY2025, three months to 2025-09-30$207.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure202Revenue, Q4 FY2025, three months to 2025-12-31$202.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure165Revenue, Q1 FY2026, three months to 2026-03-31$164.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure256Revenue, Q2 FY2026, three months to 2026-06-30$256.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Cost of revenue$m1.6Cost of revenue, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure1.9Cost of revenue, Q4 FY2023, three months to 2023-12-31$1.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure2.5Cost of revenue, Q1 FY2024, three months to 2024-03-31$2.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure2.5Cost of revenue, Q2 FY2024, three months to 2024-06-30$2.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure2.9Cost of revenue, Q3 FY2024, three months to 2024-09-30$2.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure3.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$3.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure2.4Cost of revenue, Q1 FY2025, three months to 2025-03-31$2.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure3.4Cost of revenue, Q2 FY2025, three months to 2025-06-30$3.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure4.6Cost of revenue, Q3 FY2025, three months to 2025-09-30$4.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure2.5Cost of revenue, Q4 FY2025, three months to 2025-12-31$2.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure2.9Cost of revenue, Q1 FY2026, three months to 2026-03-31$2.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure4.1Cost of revenue, Q2 FY2026, three months to 2026-06-30$4.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m45.5Research and development, Q3 FY2023, three months to 2023-09-30$45.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure54.7Research and development, Q4 FY2023, three months to 2023-12-31$54.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure58.5Research and development, Q1 FY2024, three months to 2024-03-31$58.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure58.7Research and development, Q2 FY2024, three months to 2024-06-30$58.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure59.3Research and development, Q3 FY2024, three months to 2024-09-30$59.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure70.3Research and development, Q4 FY2024, three months to 2024-12-31$70.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure60.7Research and development, Q1 FY2025, three months to 2025-03-31$60.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure60.5Research and development, Q2 FY2025, three months to 2025-06-30$60.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure68.8Research and development, Q3 FY2025, three months to 2025-09-30$68.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure64.9Research and development, Q4 FY2025, three months to 2025-12-31$64.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure66.3Research and development, Q1 FY2026, three months to 2026-03-31$66.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure53.9Research and development, Q2 FY2026, three months to 2026-06-30$53.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Selling, general and administrative$m45.3Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$45.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure47.2Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$47.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure56.3Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$56.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure66.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$66.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure73.7Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$73.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure83.4Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$83.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure90.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$90.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure104Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$103.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure124Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$124.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure130Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$130.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure145Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$145.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure157Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$156.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Operating income$m31.2Operating income, Q3 FY2023, three months to 2023-09-30$31.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure31.7Operating income, Q4 FY2023, three months to 2023-12-31$31.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure29.5Operating income, Q1 FY2024, three months to 2024-03-31$29.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure35.6Operating income, Q2 FY2024, three months to 2024-06-30$35.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure46.6Operating income, Q3 FY2024, three months to 2024-09-30$46.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure25.3Operating income, Q4 FY2024, three months to 2024-12-31$25.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure3.4Operating income, Q1 FY2025, three months to 2025-03-31$3.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure26.7Operating income, Q2 FY2025, three months to 2025-06-30$26.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure10.2Operating income, Q3 FY2025, three months to 2025-09-30$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure4.5Operating income, Q4 FY2025, three months to 2025-12-31$4.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure(49.6)Operating income, Q1 FY2026, three months to 2026-03-31−$49.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure41.3Operating income, Q2 FY2026, three months to 2026-06-30$41.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Income tax$m5.0Income tax, Q3 FY2023, three months to 2023-09-30$5.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure5.5Income tax, Q4 FY2023, three months to 2023-12-31$5.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure7.2Income tax, Q1 FY2024, three months to 2024-03-31$7.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure6.1Income tax, Q2 FY2024, three months to 2024-06-30$6.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure5.7Income tax, Q3 FY2024, three months to 2024-09-30$5.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure1.2Income tax, Q4 FY2024, three months to 2024-12-31$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure(10.9)Income tax, Q1 FY2025, three months to 2025-03-31−$10.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure(3.5)Income tax, Q2 FY2025, three months to 2025-06-30−$3.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure(4.4)Income tax, Q3 FY2025, three months to 2025-09-30−$4.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure(14.4)Income tax, Q4 FY2025, three months to 2025-12-31−$14.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure(13.0)Income tax, Q1 FY2026, three months to 2026-03-31−$13.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure2.9Income tax, Q2 FY2026, three months to 2026-06-30$2.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Net income$m31.4Net income, Q3 FY2023, three months to 2023-09-30$31.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure31.4Net income, Q4 FY2023, three months to 2023-12-31$31.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure27.8Net income, Q1 FY2024, three months to 2024-03-31$27.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure35.5Net income, Q2 FY2024, three months to 2024-06-30$35.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure47.2Net income, Q3 FY2024, three months to 2024-09-30$47.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure30.7Net income, Q4 FY2024, three months to 2024-12-31$30.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure20.5Net income, Q1 FY2025, three months to 2025-03-31$20.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure35.1Net income, Q2 FY2025, three months to 2025-06-30$35.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure19.7Net income, Q3 FY2025, three months to 2025-09-30$19.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure24.3Net income, Q4 FY2025, three months to 2025-12-31$24.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure(31.8)Net income, Q1 FY2026, three months to 2026-03-31−$31.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure43.0Net income, Q2 FY2026, three months to 2026-06-30$43.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Diluted EPS$ per share0.28Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figurenot reported0.25Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure0.32Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure0.41Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figurenot reported0.17Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure0.29Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure0.16Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figurenot reported(0.30)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure0.36Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Basic EPS$ per share0.31Basic EPS, Q3 FY2023, three months to 2023-09-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figurenot reported0.27Basic EPS, Q1 FY2024, three months to 2024-03-31$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure0.34Basic EPS, Q2 FY2024, three months to 2024-06-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure0.45Basic EPS, Q3 FY2024, three months to 2024-09-30$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figurenot reported0.19Basic EPS, Q1 FY2025, three months to 2025-03-31$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure0.33Basic EPS, Q2 FY2025, three months to 2025-06-30$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure0.19Basic EPS, Q3 FY2025, three months to 2025-09-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figurenot reported(0.30)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure0.40Basic EPS, Q2 FY2026, three months to 2026-06-30$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure

Balance sheet

Cash and equivalents$111.0m, Q2 FY2026
Shareholders' equity$705.8m, Q2 FY2026
Corcept Therapeutics Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m112Cash and equivalents, Q3 FY2023, at 2023-09-30$111.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-01, accession 0001628280-23-035988.Report this figure136Cash and equivalents, FY2023, at 2023-12-31$135.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-26, accession 0001628280-25-008167.Report this figure150Cash and equivalents, Q1 FY2024, at 2024-03-31$149.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-01, accession 0001628280-24-019610.Report this figure129Cash and equivalents, Q2 FY2024, at 2024-06-30$128.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-29, accession 0001628280-24-033284.Report this figure137Cash and equivalents, Q3 FY2024, at 2024-09-30$137.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure128Cash and equivalents, FY2024, at 2024-12-31$127.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001628280-26-011091.Report this figure89.8Cash and equivalents, Q1 FY2025, at 2025-03-31$89.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure103Cash and equivalents, Q2 FY2025, at 2025-06-30$102.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure125Cash and equivalents, Q3 FY2025, at 2025-09-30$125.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure120Cash and equivalents, FY2025, at 2025-12-31$120.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure109Cash and equivalents, Q1 FY2026, at 2026-03-31$108.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure111Cash and equivalents, Q2 FY2026, at 2026-06-30$111.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Current assets$m432Current assets, Q3 FY2023, at 2023-09-30$431.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-01, accession 0001628280-23-035988.Report this figure459Current assets, FY2023, at 2023-12-31$458.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-26, accession 0001628280-25-008167.Report this figure503Current assets, Q1 FY2024, at 2024-03-31$503.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-01, accession 0001628280-24-019610.Report this figure561Current assets, Q2 FY2024, at 2024-06-30$560.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-29, accession 0001628280-24-033284.Report this figure467Current assets, Q3 FY2024, at 2024-09-30$467.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure472Current assets, FY2024, at 2024-12-31$471.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-24, accession 0001628280-26-011091.Report this figure439Current assets, Q1 FY2025, at 2025-03-31$438.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure443Current assets, Q2 FY2025, at 2025-06-30$443.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure541Current assets, Q3 FY2025, at 2025-09-30$541.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure485Current assets, FY2025, at 2025-12-31$485.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure426Current assets, Q1 FY2026, at 2026-03-31$426.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure440Current assets, Q2 FY2026, at 2026-06-30$439.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Total assets$m594Total assets, Q3 FY2023, at 2023-09-30$594.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-01, accession 0001628280-23-035988.Report this figure622Total assets, FY2023, at 2023-12-31$621.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-26, accession 0001628280-25-008167.Report this figure656Total assets, Q1 FY2024, at 2024-03-31$655.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-01, accession 0001628280-24-019610.Report this figure715Total assets, Q2 FY2024, at 2024-06-30$714.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-29, accession 0001628280-24-033284.Report this figure784Total assets, Q3 FY2024, at 2024-09-30$784.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure841Total assets, FY2024, at 2024-12-31$840.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-24, accession 0001628280-26-011091.Report this figure846Total assets, Q1 FY2025, at 2025-03-31$846.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure802Total assets, Q2 FY2025, at 2025-06-30$801.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure824Total assets, Q3 FY2025, at 2025-09-30$823.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure837Total assets, FY2025, at 2025-12-31$836.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure815Total assets, Q1 FY2026, at 2026-03-31$814.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure889Total assets, Q2 FY2026, at 2026-06-30$888.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Current liabilities$m122Current liabilities, Q3 FY2023, at 2023-09-30$121.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-01, accession 0001628280-23-035988.Report this figure105Current liabilities, FY2023, at 2023-12-31$104.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-26, accession 0001628280-25-008167.Report this figure97.2Current liabilities, Q1 FY2024, at 2024-03-31$97.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-01, accession 0001628280-24-019610.Report this figure101Current liabilities, Q2 FY2024, at 2024-06-30$100.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-29, accession 0001628280-24-033284.Report this figure126Current liabilities, Q3 FY2024, at 2024-09-30$126.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure141Current liabilities, FY2024, at 2024-12-31$140.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-24, accession 0001628280-26-011091.Report this figure143Current liabilities, Q1 FY2025, at 2025-03-31$143.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure145Current liabilities, Q2 FY2025, at 2025-06-30$144.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure172Current liabilities, Q3 FY2025, at 2025-09-30$172.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure166Current liabilities, FY2025, at 2025-12-31$166.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure149Current liabilities, Q1 FY2026, at 2026-03-31$149.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure154Current liabilities, Q2 FY2026, at 2026-06-30$153.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Total liabilities$m132Total liabilities, Q3 FY2023, at 2023-09-30$132.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-01, accession 0001628280-23-035988.Report this figure115Total liabilities, FY2023, at 2023-12-31$114.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-26, accession 0001628280-25-008167.Report this figure108Total liabilities, Q1 FY2024, at 2024-03-31$108.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-01, accession 0001628280-24-019610.Report this figure118Total liabilities, Q2 FY2024, at 2024-06-30$118.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-29, accession 0001628280-24-033284.Report this figure145Total liabilities, Q3 FY2024, at 2024-09-30$145.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure161Total liabilities, FY2024, at 2024-12-31$161.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-24, accession 0001628280-26-011091.Report this figure163Total liabilities, Q1 FY2025, at 2025-03-31$163.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure166Total liabilities, Q2 FY2025, at 2025-06-30$165.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure192Total liabilities, Q3 FY2025, at 2025-09-30$191.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure189Total liabilities, FY2025, at 2025-12-31$188.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure177Total liabilities, Q1 FY2026, at 2026-03-31$176.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure183Total liabilities, Q2 FY2026, at 2026-06-30$182.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m462Shareholders' equity, Q3 FY2023, at 2023-09-30$461.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure507Shareholders' equity, FY2023, at 2023-12-31$506.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-24, accession 0001628280-26-011091.Report this figure548Shareholders' equity, Q1 FY2024, at 2024-03-31$547.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure596Shareholders' equity, Q2 FY2024, at 2024-06-30$596.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure639Shareholders' equity, Q3 FY2024, at 2024-09-30$638.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure680Shareholders' equity, FY2024, at 2024-12-31$679.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure683Shareholders' equity, Q1 FY2025, at 2025-03-31$683.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure636Shareholders' equity, Q2 FY2025, at 2025-06-30$635.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure632Shareholders' equity, Q3 FY2025, at 2025-09-30$631.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure648Shareholders' equity, FY2025, at 2025-12-31$647.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure638Shareholders' equity, Q1 FY2026, at 2026-03-31$638.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure706Shareholders' equity, Q2 FY2026, at 2026-06-30$705.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure

Cash flow

Operating cash flow$33.5m, Q2 FY2026
Capital expenditure$2.5m, Q2 FY2026
Share repurchases$0, Q2 FY2026
Corcept Therapeutics Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m52.9Operating cash flow, Q3 FY2023, three months to 2023-09-30$52.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-30, accession 0001628280-24-044322. Derived: 9-month figure less the 6-month figure.Report this figure5.5Operating cash flow, Q4 FY2023, three months to 2023-12-31$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure23.8Operating cash flow, Q1 FY2024, three months to 2024-03-31$23.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure41.2Operating cash flow, Q2 FY2024, three months to 2024-06-30$41.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-31, accession 0001628280-25-037005. Derived: 6-month figure less the 3-month figure.Report this figure73.3Operating cash flow, Q3 FY2024, three months to 2024-09-30$73.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001628280-25-048841. Derived: 9-month figure less the 6-month figure.Report this figure60.1Operating cash flow, Q4 FY2024, three months to 2024-12-31$60.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure4.8Operating cash flow, Q1 FY2025, three months to 2025-03-31$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure44.3Operating cash flow, Q2 FY2025, three months to 2025-06-30$44.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001628280-26-050613. Derived: 6-month figure less the 3-month figure.Report this figure54.5Operating cash flow, Q3 FY2025, three months to 2025-09-30$54.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001628280-25-048841. Derived: 9-month figure less the 6-month figure.Report this figure38.4Operating cash flow, Q4 FY2025, three months to 2025-12-31$38.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure(16.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure33.5Operating cash flow, Q2 FY2026, three months to 2026-06-30$33.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001628280-26-050613. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$37.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-30, accession 0001628280-24-044322. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure0.4Capital expenditure, Q2 FY2024, three months to 2024-06-30$416.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-31, accession 0001628280-25-037005. Derived: 6-month figure less the 3-month figure.Report this figure1.6Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001628280-25-048841. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$121.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$104.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$57.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001628280-26-050613. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001628280-25-048841. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$50.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$201.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure2.5Capital expenditure, Q2 FY2026, three months to 2026-06-30$2.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001628280-26-050613. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-10-30, accession 0001628280-24-044322. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure0.5Share repurchases, Q1 FY2024, three months to 2024-03-31$476.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure3.5Share repurchases, Q2 FY2024, three months to 2024-06-30$3.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-07-31, accession 0001628280-25-037005. Derived: 6-month figure less the 3-month figure.Report this figure11.7Share repurchases, Q3 FY2024, three months to 2024-09-30$11.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-04, accession 0001628280-25-048841. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure27.4Share repurchases, Q1 FY2025, three months to 2025-03-31$27.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure103Share repurchases, Q2 FY2025, three months to 2025-06-30$103.0m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-29, accession 0001628280-26-050613. Derived: 6-month figure less the 3-month figure.Report this figure42.5Share repurchases, Q3 FY2025, three months to 2025-09-30$42.5m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-04, accession 0001628280-25-048841. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-24, accession 0001628280-26-011091. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure0.0Share repurchases, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-07-29, accession 0001628280-26-050613. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)118.39m, Q2 FY2026
Corcept Therapeutics Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares117Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30116,620,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-01, accession 0001628280-23-035988.Report this figure115Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31115,425,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-01, accession 0001628280-24-019610.Report this figure110Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30109,590,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-29, accession 0001628280-24-033284.Report this figure111Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30111,099,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-30, accession 0001628280-24-044322.Report this figure110Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31109,915,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-05, accession 0001628280-25-022173.Report this figure111Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30111,244,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-31, accession 0001628280-25-037005.Report this figure114Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30113,723,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure120Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31119,819,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure120Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30120,485,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure119Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30119,439,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001628280-25-048841.Report this figure104Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31104,435,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001628280-26-028902.Report this figure118Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30118,385,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure

Shares outstanding: 108.10mShares outstanding, period not labelled, at 2026-07-22108,098,397 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-29, accession 0001628280-26-050613.Report this figure at Jul 22, 2026, from the cover of the 10-Q filed Jul 29, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. Listed shows no prices and gives no investment advice.